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Stromal invasion (invasive growth of tumor tissue into portal tracts and ﬁbrous septa) is now recognized as the most important
ﬁnding in the diagnosis of the well-diﬀerentiated type of early hepatocellular carcinomas (HCCs). In diﬀerentiating stromal
invasion from pseudoinvasion (benign hepatic tissue in ﬁbrous stroma), the following 5 items are useful: (1) macroscopic or
panoramic views of the histological specimen, (2) the amount of ﬁbrous components of stroma, (3) destruction of the structure
of portal tracts, (4) loss of reticulin ﬁbers around cancer cells, and (5) cytokeratin 7 immunostaining for ductular proliferation.
Knowledge of stromal invasion is also useful for a better understanding of the vasculature (hypovascular HCCs) and histological
features (fatty change) of early HCCs. Invasion of preexisting arteries and portal veins causes hypo-vascularity of HCCs. Further,
hypovascularity causes fatty change as a hypoxic change of cancer tissues.
1.Introduction
Recently, international consensus for the histological diag-
nosis of hepatocellular carcinoma, especially of well-
diﬀerentiated type of early stage (early HCC), was published
by the International Consensus Group for Hepatocellular
Neoplasia (ICGHN) [1]. This was an epoch-making event
for the early diagnosis and early treatment of hepatocellu-
lar carcinomas (HCCs). In this consensus paper, stromal
invasion (invasive growth of tumor tissue into portal tracts
and ﬁbrous septa) was recognized as the most important
ﬁnding for the diagnosis of early HCCs. Unfortunately,
however, this ﬁnding is not commonly known except among
a small number of liver pathology experts. To present the
correct histological diagnosis of early HCCs, histological
featuresofstromalinvasionarehereinexplained,withdetails
shown in many ﬁgures. It is also described how stromal
invasioniscloselyrelatedtocharacteristicimageﬁndingsand
histological features of early HCCs.
2. History of Studies of Stromal
Invasion of HCCs
Stromal invasion, formerly called interstitial invasion of
HCC, is deﬁned as invasive growth of tumor tissue into
ﬁbrous septa, portal tracts, and/or blood vessels [2–7].
Stromal invasion by other tumors of other organs is a
commonly recognized concept, and has long been important
evidence for the deﬁnitive diagnosis of malignant tumor [8,
9].However,stromalinvasionofHCChasnotbeengenerally
known until quite recently. This ﬁnding was ﬁrst reported
as a “streak pattern” in the ﬁbrous septa of cirrhosis around
an HCC nodule by Kondo Y. et al. [2]. Kondo F. et al. then
reported that this ﬁnding was frequently found within pre-
existing portal tracts as well as ﬁbrous septa [3], emphasizing
that this ﬁnding was very useful for the diagnosis of well-
diﬀerentiated HCCs. The invasion pattern was classiﬁed
into 3 types—crossing type, longitudinal type, and irregular
type. It was also reported that stromal invasion could be
detected even by macroscopic view and by panoramic view
of a histological specimen. At that time this ﬁnding was
called “interstitial invasion” instead of “stromal invasion.”
Tomizawa et al. reported that the growth activity of well-
diﬀerentiated HCC was rather suppressed with the stromal
invasion [4]. Nakano et al. divided stromal invasion into
three types: (1) stromal invasion into ﬁbrotic tissue and/or
portal tracts, (2) blood vessel wall invasion of portal veins
or hepatic veins, and (3) tumor thrombus [5]. Miyao et al.
described that HCC tissue in the state of stromal invasion2 International Journal of Hepatology
was unaccompanied by reticulin frameworks and type IV
collagen [6].
In 1995, an International Working Party (IWP) of the
World Congress of Gastroenterology published a consensus
nomenclature and diagnostic criteria for nodular hepato-
cellular lesions [10]. In this article, stromal invasion was
listed as a criterion for the histological diagnosis of well-
and moderately diﬀerentiated HCC. Even after publication
of this article, however, this ﬁnding was still not well
known especially among pathologists in Western countries,
possibly because related articles regarding stromal invasion
were written by Japanese pathologists. This fact caused
serious diﬀerences in criteria for the diagnosis of early HCCs
between Eastern and Western pathologists.
In order to solve this serious problem, an International
Consensus Group for Hepatocellular Neoplasia (ICGHN)
was convened in April 2002 in Kurume, Japan. This group
met several times and discussed histological criteria for the
diagnosis of early HCCs subsequently, up to July 2007 [1].
In these meetings, the ﬁndings of stromal invasion were
discussed in detail. Finally, all the participants including
Western pathologists generously accepted the importance
and usefulness of this ﬁnding. Park et al. reported that
ductular reaction conﬁrmed by cytokeratin 7 (CK7) is help-
ful in deﬁning early stromal invasion, small hepatocellular
carcinomas, and dysplastic nodules (DNs) [7]. This was the
ﬁrst article of stromal invasion written by a non-Japanese
pathologist. All authors of this article were members of
ICGHN. The authors consisted of 1 Korean, 4 Western, and
4 Japanese pathologists.
In 2009, ICGHN published the consensus paper [1],
which described that stromal invasion was the most helpful
in diﬀerentiating earlyHCC from high-grade DNs. However,
this ﬁnding was not suﬃciently disseminated even after
publication of the consensus paper. To achieve progress in
the early diagnosis of many HCC patients in the world, this
ﬁnding must be explained in detail.
3.How toEvaluateStromal InvasionCorrectly:
Macroscopic andHistological Assessment of
Stromal Invasion
Stromal invasion is invasive growth of tumor tissue into
stroma (ﬁbrous septa, portal tracts, and/or blood vessels).
It is histologically classiﬁed into 3 types—crossing type,
longitudinaltype,andirregulartype(Figures1(A),1(B),and
1(C) [4].
In the crossing type, HCC invades across ﬁbrous septa
of tumor nodules (Figure 1(A)). In the longitudinal type,
tumor cells grow longitudinally within ﬁbrous septa (Figure
1(B)). In the irregular type, portal areas are irregularly
invaded by tumor cells (Figure 1(C)). The crossing type
is usually observed in moderately or poorly diﬀerentiated
HCCs whereas the longitudinal and irregular types are
usually found in well-diﬀerentiated HCCs, although also at
times in moderately or poorly diﬀerentiated HCCs. In the
evaluation of stromal invasion, comparison of cancer areas
with noncancerous areas is very useful (Figure 1(D)), and
we have to diﬀerentiate “pseudo-invasion” from true stromal
invasion. Pseudo-invasion means benign non-cancerous
tissue in the ﬁbrous stroma (Figure 1(E)), and this does
resemble stromal invasion.
For the diﬀerentiation, the following factors are very
useful.
(1) Macroscopic and/or panoramic (low-magniﬁcation)
views of the nodule.
(2) Amount of ﬁbrous components of the stroma.
(3) Continuity to vascular invasion and destruction of
the structure of portal tracts.
(4) Loss of reticulin ﬁbers around tumor cells.
(5) Cytokeratin 7 immunostaining.
Stromal invasion can be identiﬁed even by a macro-
scopic and/or panoramic view of histological specimens.
As is seen in Figure 1(F) (macroscopic view of HCC),
in the non-cancerous area without invasion (area of (a)),
the ﬁbrous septa are clearly visible. However, in the area
of tumor spread (area of (b)), the septa are indistinct.
Similarly, in a panoramic view of a histological specimen
of HCC (Figure 1(G)), distinct ﬁbrous septa (area of (a))
and indistinct ﬁbrous septa (area of (b)) can be clearly
identiﬁed. In these indistinct septa, tumor invasion was
then detected by microscope (Figures 1(B) and 1(C)). The
amount of the ﬁbrous component is quite diﬀerent between
the invasive and noninvasive areas, an important point for
the diﬀerentiation from pseudo-invasion. The amount of
the ﬁbrous component was decreased as a result of the
tumor invasion, and this decrease caused the indistinctness
of the ﬁbrous septa. Pseudo-invasion is usually caused by
ﬁbrosis around benign non-cancerous liver tissue. Therefore,
it does not show reduction in the ﬁbrous component. When
stromal invasion is very mild and ﬁbrous components are
minimally reduced, histological and macroscopic assessment
of stromal invasion is diﬃcult. However, stromal invasion is
severe enough, histological and macroscopic assessment is
easy (Figures 1(F) and 1(G)). Even in cases of HCCs with
minimal invasion and DNs, proportion of ﬁbrous stroma
or portal tracts are reduced to some extent as described
later. Therefore, macroscopic view is helpful for recognizing
eHCC and DN. The continuity to vascular invasion and
destruction of the structure of portal tracts are also impor-
tant ﬁndings (Figure 1(H)). The former is a decisive ﬁnding
of malignancy. Although it is not a common ﬁnding, it can
be detected in some early HCCs. Tumor tissue ﬁrst invades
into ﬁbrous septa, then into vascular walls, and ﬁnally into
vascularlumina.Theconnectionamongendothelialcellswas
most certainly destroyed by the mechanical force exerted
by tumor growth. Portal vein invasion in Figure 1(H) is
in vascular space. It means tumor cells are disseminated
in circulation. However, tumor cell dissemination does not
directly cause metastasis. Before forming metastatic foci,
tumor cells have to survive within circulation, have to reach
to remote areas, have to invade vascular walls from inside
to outside, and have to proliferate outside the blood vessels.
Interpretation of tumor cells in the subendothelial spaceInternational Journal of Hepatology 3
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Figure 1: Various features of stromal invasion of hepatocellular carcinoma (HCC) and pseudo-invasion (A) Crossing type. Cancer tissue
(HCC) invades across ﬁbrous septa (f) of tumor nodule. (B) Longitudinal type. Tumor cells grow longitudinally within ﬁbrous septa
(arrowheads). (C) Irregular type. Portal areas are irregularly invaded by tumor cells (Masson trichrome stain). (D) A non-cancerous area
without invasion, and a portal area and ﬁbrous septa are clearly seen. (E) Pseudo-invasion. Benign non-cancerous cells are found in the
ﬁbrous stroma (Masson trichrome stain). (F) Macroscopic view of stromal invasion. In the non-cancerous area without invasion (area of
(a)), ﬁbrous septa are clearly seen. In the area of tumor spread (area of (b)), septa are indistinct. (G) A panoramic view of stromal invasion.
In the same way as in (F), the non-cancerous area without invasion (area of (a)) shows distinct ﬁbrous septa. The area of tumor spread
(area of (b)) shows indistinct septa because stromal invasion of longitudinal type and irregular type ((B), (C)) reduced the amount of
ﬁbrous component. (H) Continuity of ﬁbrous invasion and vascular invasion. The arrows show portal vein (p) invasion. Vascular invasion
is continuous to stromal invasion of ﬁbrous tissue of the portal “tract” and ﬁbrous septum (Masson trichrome stain). (I) Masson trichrome
staining of pseudoinvasion. (J) Silver staining of the same specimen as (I). Liver cells are clearly surrounded by reticulin ﬁbers. (K) Masson
trichrome staining of true invasion. (L) Silver staining of the same specimen as (K). Carcinoma cells are not surrounded by reticulin ﬁbers.
(M) (N) Cytokeratin (CK) 7 immunostaining in a non-cancerous area (M) and cancerous area (N). (M) Ductular reaction, conﬁrmed by
CK 7 staining, is clearly seen in a non-cancerous, non-invasive area. (N) Ductular reaction is not found in the invasive area. (N) Adapted
from Y. Kondo et al. [2], F. Kondo et al. [3], and from F. Kondo [11].
is controversial. It can be true sub-endothelial invasion.
However, it can be interpreted as blood space invasion after
re-covering with endothelial cells. Endothelial cells can easily
cover intravascular foreign substance. Destruction of the
portal tract structure is more frequently found in stromal
invasion while this feature is not seen in pseudo-invasion
(Figure 1(E)).
Loss of reticulin ﬁbers around the tumor cells is another
useful ﬁnding [7]. Figures 1(I) and 1(J) show Masson
trichrome staining and silver staining of pseudo-invasion.
And Figures 1(K) and 1(L) show those of true invasion,
respectively. Magniﬁcation of Figures 1(J) and 1(L) is a
little higher than that of Figures 1(I) and 1(K). The liver
parenchyma is clearly surrounded by reticulin ﬁbers in the
pseudo-invasion (Figure 1(J)). By contrast, the liver tissue
of the true invasion lacks such surrounding reticulin ﬁbers
(Figure 1(L)). Tumor cells are embedded in the septal ﬁbers
without being clothed by reticulin ﬁbers.
As described above, Park et al. reported that CK7
immunostaining is useful for identifying stromal invasion
[7]. Ductular reaction conﬁrmed by CK7 staining is fre-
quently found in non-cancerous hepatocellular nodular
lesions (Figure 1(M)) while it is less frequently found in
HCCs with true stromal invasion (Figure 1(N)). Ductules
around the ﬁbrous septa are non-cancerous components.
They must have been invaded by well-diﬀerentiated HCC
cells around the ﬁbrous septa or by HCC cells from the
ﬁbrous septa.
For the correct assessment of true stromal invasion, these
silver and CK7 stainings are useful. Masson trichrome stain,
Azan-Mallorystain,andVictoriabluestainarealsousefulfor
clarifying the ﬁbrous components.International Journal of Hepatology 5
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Figure 2: Histological features which make the assessment of stromal invasion diﬃcult (a) True stromal invasion of very mild grade. The
ﬁbrous septum is almost intact except for a small area (arrow). (b) Pseudo-invasion consisting of very thin ﬁbrous bundles within and
around thick liver cell cords. This pattern was formed by dissection of liver parenchyma by very thin ﬁbrous tissue. (c) A specimen of very
poorly performed silver stain. (d) Silver stain of HCC tissue within and around a ﬁbrous septum. Reticulin ﬁbers circumscribing cancer
tissue are seen even in the area of true invasion (yellow arrow). However, noncircumscribed tumor cells are also seen in the same ﬁbrous
septum (green arrows). This area is a “battle front” of invasion. Red arrows show ordinary tumor tissue with reticulin ﬁbers surrounding the
ﬁbrous tissue.
Next,somehistologicalfeaturesthatmaketheassessment
of stromal invasion diﬃcult must be shown (Figure 2).
Figure 2(a) shows true stromal invasion of a very mild
grade. The ﬁbrous septum is almost intact except for a small
area(arrow).Bycontrast,Figure 2(b)showspseudo-invasion
consisting of very thin ﬁbrous bundles within and around
thick liver cell cords. This pattern was not formed by the
reduction of ﬁbrous component but rather by dissection
of liver parenchyma by very thin ﬁbrous tissue. Observing
these two ﬁgures, pathologists may doubt the concept of
stromal invasion. In such cases, however, silver stain is
very useful. Reticulin ﬁbers are lost in the case of true
invasion but not in the case of pseudo-invasion. In cases like
Figure 2(a), I recommend pathologists to search for more
severely invaded portal tracts that can easily be assessed as
trueinvasion.Evenverywell-diﬀerentiatedHCCssometimes
include severely invaded portal tracts as well as minimally
invaded portal tracts. Figure 2(c) shows a specimen of
very poorly performed silver staining. Such poorly stained
specimen makes the diagnosis diﬃcult.
Figure 2(d) shows that reticulin ﬁbers sometimes cir-
cumscribe cancer tissue even in the area of true invasion
(yellow arrow). However, noncircumscribed cells are usually
seen in the same ﬁbrous septum (green arrows). This area
is a “battle front” of invasion. By contrast, red arrows show
ordinarytumortissuewithreticulinﬁbersoutsidetheﬁbrous
tissue. In fact, reticulin ﬁbers are sometimes observed within
and around true invasive areas. After the invasive process is
over, the cancer cells form ordinary cancer areas. In such
phase of tumor growth, reticulin ﬁbers must be formed
again.
4. Inﬂuence of Stromal Invasion on Images and
Histological Featuresof EarlyHCCs
Stromalinvasioniscloselyrelatedtotheimagesandhistolog-
ical features of early HCCs. Figure 3 shows the relationship
betweencancerdevelopment,vascularity,histologicalfeature
(fatty change), and stromal invasion. Although there exists
no direct evidence in a strict meaning, the possibility or6 International Journal of Hepatology
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Figure 3: Relationship between cancer development, vascularity, histological feature (fatty change), and stromal invasion.
hypothesis shown in Figure 3 well explains the formation
mechanismofvascularitiesandfattychangeofHCC.Atleast,
previous studies [12–18] can be good indirect evidence for
thedescriptioninFigure 3.Well-diﬀerentiatedHCCsemerge
from non-cancerous liver tissues (normal liver, regenerative
nodules, and DNs), and then they progress into moderately
orpoorlydiﬀerentiatedHCCs.Vascularity(usuallyevaluated
by contrast medium-enhanced images) changes during this
process. Well-diﬀerentiated HCCs are usually hypo-vascular
lesions [12–17]. This hypo-vascularity means a decrease in
pre-existing arterial and portal venous blood supply caused
by stromal invasion. During the process in which a well-
diﬀerentiated HCC progresses into a moderately or poorly
diﬀerentiated HCC, vascularity usually changes to become
hypervascular [12–17]. This vascular change is caused
by proliferation of abnormal arteries (neovascularization)
[1, 17].
As a matter of fact, abnormal arteries are found within
DNs [1, 17] .H o w e v e r ,t h ei n c r e a s eo fa r t e r i e si sn o t
suﬃcient to cause hyper-vascularity. DNs sometimes show
hypo-vascularity without stromal invasion [17]. This hypo-
vascularity is attributed to a relative decrease of density of
pre-existing portal tracts. Because the parenchymal com-
ponent increases within the DN nodule, the density of
pre-existing portal tracts decreases. After DNs transforms
into early HCCs, the density may decrease more severely
by stromal invasion. This process must have caused hypo-
vascularity of early HCCs.
This hypo-vascularity can also explain the formation
mechanism of fatty change, a well-known feature of
early HCCs (Figure 3)[ 18]. Although fatty change may
be attributed to metabolic change of tumor cells with
tumor development independent of hypoxic change, hypo-
vascularity may cause fatty change as a hypoxic change.
As mentioned above, knowledge of stromal invasion is
very useful to understanding the vascularity and histological
features of early HCCs.
5. Limitationsof Assessment of
Stromal Invasion
Finally, limitations of the assessment of stromal invasion
have to be described. Stromal invasion cannot always be
assessed histologically, and it is very rarely assessed in the
examination of thin-needle biopsy specimens [11]. Biopsy
specimens are simply too small to allow examination of stro-
mal invasion. For this reason, very well diﬀerentiated HCCs
lacking typical features of ordinary well-diﬀerentiated HCCs
are not diagnosed by biopsy [11]. As histological criteria
for the biopsy diagnosis of well-diﬀerentiated HCCs, (1)
nuclear crowding (hypercellularity), (2) hyperstainability of
cytoplasm (basophilia or eosinophilia), and (3) microacinar
formation have been used til now [19]. These criteria have
beenprovedtobeusefulbecauseordinarywell-diﬀerentiated
HCCshaveconsiderableparenchymalatypia.However,some
very well-diﬀerentiated HCCs are not diagnosed by biopsy
and are deﬁnitively diagnosed after examination of stromal
invasion in resected specimens.
To make progress in the early diagnosis of HCCs, we
have to develop new parenchymal tumor markers that can
be used for biopsy diagnosis. Some attempts have been made
recently to utilize immunohistochemical markers for the
diagnosis of well-diﬀerentiated HCCs [20–25]. Heat shock
protein 70 (HSP70) [20, 21], glypican 3 (GPC3) [20, 22, 23],
and glutamine synthetase (GS) [20, 24, 25] have been used
independently or in combination. At present, these markers
are used in a complementary manner to morphological
criteria. Newer markers have also been tried [26, 27]. We are
hopeful that excellent markers with high sensitivity and high
speciﬁcity are developed in the future.
6. Conclusions
(1) Stromal invasion is a very important ﬁnding for the
histological diagnosis of early HCCs.International Journal of Hepatology 7
(2) For the correct assessment of stromal invasion, the
following 5 items are useful: (1) macroscopic or
panoramic views of the histological specimen, (2)
amount of ﬁbrous components of the stroma, (3)
destruction of the structure of portal tracts, (4) loss
of reticulin ﬁbers around cancer cells, and (5) CK 7
immunostaining for ductular proliferation.
(3) Knowledge of stromal invasion is very useful to
understand the formation mechanism of images
(vascularity) and histological features (fatty change)
of early HCCs.
(4) Stromal invasion cannot be assessed in thin-needle
biopsy specimens.
(5) New parenchymal tumor markers usable for biopsy
diagnosis need to be developed.
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